Global Taletrectinib Adipate Supply, Demand and Key Producers, 2026-2032
The global Taletrectinib Adipate market size is expected to reach $ 436 million by 2032, rising at a market growth of 25.2% CAGR during the forecast period (2026-2032).
Taletrectinib Adipate is an oral, highly selective small?molecule tyrosine kinase inhibitor and a new generation of antineoplastic agent targeting ROS1 and NTRK fusion genes. It exerts potent antitumor activity by selectively inhibiting ROS1 and NTRK kinase activities, blocking downstream signaling pathways involved in tumor cell proliferation, differentiation and metastasis. It demonstrates significant inhibitory activity against crizotinib?resistant mutations such as ROS1 G2032R. It is mainly indicated for the treatment of ROS1?positive advanced or metastatic non?small cell lung cancer and NTRK fusion?positive solid tumors, characterized by strong antitumor activity, excellent central nervous system penetration and broad coverage of resistant mutationsIn 2025, global taletrectinib adipate (????????brand name Ibtrozi) production reached approximately 120,000–150,000 bottles
Taletrectinib adipate demonstrates significant market competitiveness in the global treatment of ROS1 and NTRK fusion-positive tumors owing to its excellent target selectivity, potent intracranial antitumor activity, and favorable control over drug-resistant mutations. With the popularization of precision medicine and genetic testing, the clinical demand for such targeted drugs continues to rise. By virtue of its superior efficacy and safety compared with first-generation products, taletrectinib adipate has gradually become an important option for the treatment of advanced non-small cell lung cancer and solid tumors. Driven by policy support at home and abroad, the advancement of medical insurance access, and global commercialization layout, its market coverage has been continuously expanded and patient accessibility steadily improved. The overall market shows a steady growth trend, with broad application prospects and promising market potential in both first-line and post-resistance treatment settings.
This report studies the global Taletrectinib Adipate production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Taletrectinib Adipate and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Taletrectinib Adipate that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Taletrectinib Adipate total production and demand, 2021-2032, (Units)
Global Taletrectinib Adipate total production value, 2021-2032, (USD Million)
Global Taletrectinib Adipate production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Taletrectinib Adipate consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Taletrectinib Adipate domestic production, consumption, key domestic manufacturers and share
Global Taletrectinib Adipate production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Taletrectinib Adipate production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Taletrectinib Adipate production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Taletrectinib Adipate market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AnHeart Therapeutics, Innovent Biologics, Asymchem Life Sciences Tianjin) C, Daiichi Sankyo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Taletrectinib Adipate market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Taletrectinib Adipate Market, By Region:
1. How big is the global Taletrectinib Adipate market?
2. What is the demand of the global Taletrectinib Adipate market?
3. What is the year over year growth of the global Taletrectinib Adipate market?
4. What is the production and production value of the global Taletrectinib Adipate market?
5. Who are the key producers in the global Taletrectinib Adipate market?
6. What are the growth factors driving the market demand?
Taletrectinib Adipate is an oral, highly selective small?molecule tyrosine kinase inhibitor and a new generation of antineoplastic agent targeting ROS1 and NTRK fusion genes. It exerts potent antitumor activity by selectively inhibiting ROS1 and NTRK kinase activities, blocking downstream signaling pathways involved in tumor cell proliferation, differentiation and metastasis. It demonstrates significant inhibitory activity against crizotinib?resistant mutations such as ROS1 G2032R. It is mainly indicated for the treatment of ROS1?positive advanced or metastatic non?small cell lung cancer and NTRK fusion?positive solid tumors, characterized by strong antitumor activity, excellent central nervous system penetration and broad coverage of resistant mutationsIn 2025, global taletrectinib adipate (????????brand name Ibtrozi) production reached approximately 120,000–150,000 bottles
Taletrectinib adipate demonstrates significant market competitiveness in the global treatment of ROS1 and NTRK fusion-positive tumors owing to its excellent target selectivity, potent intracranial antitumor activity, and favorable control over drug-resistant mutations. With the popularization of precision medicine and genetic testing, the clinical demand for such targeted drugs continues to rise. By virtue of its superior efficacy and safety compared with first-generation products, taletrectinib adipate has gradually become an important option for the treatment of advanced non-small cell lung cancer and solid tumors. Driven by policy support at home and abroad, the advancement of medical insurance access, and global commercialization layout, its market coverage has been continuously expanded and patient accessibility steadily improved. The overall market shows a steady growth trend, with broad application prospects and promising market potential in both first-line and post-resistance treatment settings.
This report studies the global Taletrectinib Adipate production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Taletrectinib Adipate and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Taletrectinib Adipate that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Taletrectinib Adipate total production and demand, 2021-2032, (Units)
Global Taletrectinib Adipate total production value, 2021-2032, (USD Million)
Global Taletrectinib Adipate production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Taletrectinib Adipate consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Taletrectinib Adipate domestic production, consumption, key domestic manufacturers and share
Global Taletrectinib Adipate production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Taletrectinib Adipate production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Taletrectinib Adipate production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Taletrectinib Adipate market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AnHeart Therapeutics, Innovent Biologics, Asymchem Life Sciences Tianjin) C, Daiichi Sankyo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Taletrectinib Adipate market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Taletrectinib Adipate Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 33 capsules / bottle
- 30 capsules / bottle
- ROS1 Fusion Gene-Positive Adult Patients with Advanced or Metastatic Non-Small Cell Lung Cancer**
- NTRK Fusion Gene-Positive Patients with Advanced Solid Tumors**
- Hospitals
- Retail
- Online
- Original
- Generic
- Ros1 Fusion-Positive Locally Advanced
- Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Others
- AnHeart Therapeutics
- Innovent Biologics
- Asymchem Life Sciences Tianjin) C
- Daiichi Sankyo
1. How big is the global Taletrectinib Adipate market?
2. What is the demand of the global Taletrectinib Adipate market?
3. What is the year over year growth of the global Taletrectinib Adipate market?
4. What is the production and production value of the global Taletrectinib Adipate market?
5. Who are the key producers in the global Taletrectinib Adipate market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Taletrectinib Adipate Introduction
1.2 World Taletrectinib Adipate Supply & Forecast
1.2.1 World Taletrectinib Adipate Production Value (2021 & 2025 & 2032)
1.2.2 World Taletrectinib Adipate Production (2021-2032)
1.2.3 World Taletrectinib Adipate Pricing Trends (2021-2032)
1.3 World Taletrectinib Adipate Production by Region (Based on Production Site)
1.3.1 World Taletrectinib Adipate Production Value by Region (2021-2032)
1.3.2 World Taletrectinib Adipate Production by Region (2021-2032)
1.3.3 World Taletrectinib Adipate Average Price by Region (2021-2032)
1.3.4 North America Taletrectinib Adipate Production (2021-2032)
1.3.5 Europe Taletrectinib Adipate Production (2021-2032)
1.3.6 China Taletrectinib Adipate Production (2021-2032)
1.3.7 Japan Taletrectinib Adipate Production (2021-2032)
1.3.8 India Taletrectinib Adipate Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Taletrectinib Adipate Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Taletrectinib Adipate Major Market Trends
2 DEMAND SUMMARY
2.1 World Taletrectinib Adipate Demand (2021-2032)
2.2 World Taletrectinib Adipate Consumption by Region
2.2.1 World Taletrectinib Adipate Consumption by Region (2021-2026)
2.2.2 World Taletrectinib Adipate Consumption Forecast by Region (2027-2032)
2.3 United States Taletrectinib Adipate Consumption (2021-2032)
2.4 China Taletrectinib Adipate Consumption (2021-2032)
2.5 Europe Taletrectinib Adipate Consumption (2021-2032)
2.6 Japan Taletrectinib Adipate Consumption (2021-2032)
2.7 South Korea Taletrectinib Adipate Consumption (2021-2032)
2.8 ASEAN Taletrectinib Adipate Consumption (2021-2032)
2.9 India Taletrectinib Adipate Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Taletrectinib Adipate Production Value by Manufacturer (2021-2026)
3.2 World Taletrectinib Adipate Production by Manufacturer (2021-2026)
3.3 World Taletrectinib Adipate Average Price by Manufacturer (2021-2026)
3.4 Taletrectinib Adipate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Taletrectinib Adipate Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Taletrectinib Adipate in 2025
3.5.3 Global Concentration Ratios (CR8) for Taletrectinib Adipate in 2025
3.6 Taletrectinib Adipate Market: Overall Company Footprint Analysis
3.6.1 Taletrectinib Adipate Market: Region Footprint
3.6.2 Taletrectinib Adipate Market: Company Product Type Footprint
3.6.3 Taletrectinib Adipate Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Taletrectinib Adipate Production Value Comparison
4.1.1 United States VS China: Taletrectinib Adipate Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Taletrectinib Adipate Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Taletrectinib Adipate Production Comparison
4.2.1 United States VS China: Taletrectinib Adipate Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Taletrectinib Adipate Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Taletrectinib Adipate Consumption Comparison
4.3.1 United States VS China: Taletrectinib Adipate Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Taletrectinib Adipate Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Taletrectinib Adipate Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Taletrectinib Adipate Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Taletrectinib Adipate Production Value (2021-2026)
4.4.3 United States Based Manufacturers Taletrectinib Adipate Production (2021-2026)
4.5 China Based Taletrectinib Adipate Manufacturers and Market Share
4.5.1 China Based Taletrectinib Adipate Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Taletrectinib Adipate Production Value (2021-2026)
4.5.3 China Based Manufacturers Taletrectinib Adipate Production (2021-2026)
4.6 Rest of World Based Taletrectinib Adipate Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Taletrectinib Adipate Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Taletrectinib Adipate Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Taletrectinib Adipate Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Taletrectinib Adipate Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 33 capsules / bottle
5.2.2 30 capsules / bottle
5.3 Market Segment by Type
5.3.1 World Taletrectinib Adipate Production by Type (2021-2032)
5.3.2 World Taletrectinib Adipate Production Value by Type (2021-2032)
5.3.3 World Taletrectinib Adipate Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY INDICATED POPULATION
6.1 World Taletrectinib Adipate Market Size Overview by Indicated Population: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Indicated Population
6.2.1 ROS1 Fusion Gene-Positive Adult Patients with Advanced or Metastatic Non-Small Cell Lung Cancer**
6.2.2 NTRK Fusion Gene-Positive Patients with Advanced Solid Tumors**
6.3 Market Segment by Indicated Population
6.3.1 World Taletrectinib Adipate Production by Indicated Population (2021-2032)
6.3.2 World Taletrectinib Adipate Production Value by Indicated Population (2021-2032)
6.3.3 World Taletrectinib Adipate Average Price by Indicated Population (2021-2032)
7 MARKET ANALYSIS BY SALES CHANNELS
7.1 World Taletrectinib Adipate Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sales Channels
7.2.1 Hospitals
7.2.2 Retail
7.2.3 Online
7.3 Market Segment by Sales Channels
7.3.1 World Taletrectinib Adipate Production by Sales Channels (2021-2032)
7.3.2 World Taletrectinib Adipate Production Value by Sales Channels (2021-2032)
7.3.3 World Taletrectinib Adipate Average Price by Sales Channels (2021-2032)
8 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
8.1 World Taletrectinib Adipate Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Production Technology
8.2.1 Original
8.2.2 Generic
8.3 Market Segment by Production Technology
8.3.1 World Taletrectinib Adipate Production by Production Technology (2021-2032)
8.3.2 World Taletrectinib Adipate Production Value by Production Technology (2021-2032)
8.3.3 World Taletrectinib Adipate Average Price by Production Technology (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Taletrectinib Adipate Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Ros1 Fusion-Positive Locally Advanced
9.2.2 Metastatic Non-Small Cell Lung Cancer (NSCLC)
9.2.3 Others
9.3 Market Segment by Application
9.3.1 World Taletrectinib Adipate Production by Application (2021-2032)
9.3.2 World Taletrectinib Adipate Production Value by Application (2021-2032)
9.3.3 World Taletrectinib Adipate Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 AnHeart Therapeutics
10.1.1 AnHeart Therapeutics Details
10.1.2 AnHeart Therapeutics Major Business
10.1.3 AnHeart Therapeutics Taletrectinib Adipate Product and Services
10.1.4 AnHeart Therapeutics Taletrectinib Adipate Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 AnHeart Therapeutics Recent Developments/Updates
10.1.6 AnHeart Therapeutics Competitive Strengths & Weaknesses
10.2 Innovent Biologics
10.2.1 Innovent Biologics Details
10.2.2 Innovent Biologics Major Business
10.2.3 Innovent Biologics Taletrectinib Adipate Product and Services
10.2.4 Innovent Biologics Taletrectinib Adipate Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Innovent Biologics Recent Developments/Updates
10.2.6 Innovent Biologics Competitive Strengths & Weaknesses
10.3 Asymchem Life Sciences Tianjin) C
10.3.1 Asymchem Life Sciences Tianjin) C Details
10.3.2 Asymchem Life Sciences Tianjin) C Major Business
10.3.3 Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Product and Services
10.3.4 Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Asymchem Life Sciences Tianjin) C Recent Developments/Updates
10.3.6 Asymchem Life Sciences Tianjin) C Competitive Strengths & Weaknesses
10.4 Daiichi Sankyo
10.4.1 Daiichi Sankyo Details
10.4.2 Daiichi Sankyo Major Business
10.4.3 Daiichi Sankyo Taletrectinib Adipate Product and Services
10.4.4 Daiichi Sankyo Taletrectinib Adipate Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Daiichi Sankyo Recent Developments/Updates
10.4.6 Daiichi Sankyo Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Taletrectinib Adipate Industry Chain
11.2 Taletrectinib Adipate Upstream Analysis
11.2.1 Taletrectinib Adipate Core Raw Materials
11.2.2 Main Manufacturers of Taletrectinib Adipate Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Taletrectinib Adipate Production Mode
11.6 Taletrectinib Adipate Procurement Model
11.7 Taletrectinib Adipate Industry Sales Model and Sales Channels
11.7.1 Taletrectinib Adipate Sales Model
11.7.2 Taletrectinib Adipate Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Taletrectinib Adipate Introduction
1.2 World Taletrectinib Adipate Supply & Forecast
1.2.1 World Taletrectinib Adipate Production Value (2021 & 2025 & 2032)
1.2.2 World Taletrectinib Adipate Production (2021-2032)
1.2.3 World Taletrectinib Adipate Pricing Trends (2021-2032)
1.3 World Taletrectinib Adipate Production by Region (Based on Production Site)
1.3.1 World Taletrectinib Adipate Production Value by Region (2021-2032)
1.3.2 World Taletrectinib Adipate Production by Region (2021-2032)
1.3.3 World Taletrectinib Adipate Average Price by Region (2021-2032)
1.3.4 North America Taletrectinib Adipate Production (2021-2032)
1.3.5 Europe Taletrectinib Adipate Production (2021-2032)
1.3.6 China Taletrectinib Adipate Production (2021-2032)
1.3.7 Japan Taletrectinib Adipate Production (2021-2032)
1.3.8 India Taletrectinib Adipate Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Taletrectinib Adipate Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Taletrectinib Adipate Major Market Trends
2 DEMAND SUMMARY
2.1 World Taletrectinib Adipate Demand (2021-2032)
2.2 World Taletrectinib Adipate Consumption by Region
2.2.1 World Taletrectinib Adipate Consumption by Region (2021-2026)
2.2.2 World Taletrectinib Adipate Consumption Forecast by Region (2027-2032)
2.3 United States Taletrectinib Adipate Consumption (2021-2032)
2.4 China Taletrectinib Adipate Consumption (2021-2032)
2.5 Europe Taletrectinib Adipate Consumption (2021-2032)
2.6 Japan Taletrectinib Adipate Consumption (2021-2032)
2.7 South Korea Taletrectinib Adipate Consumption (2021-2032)
2.8 ASEAN Taletrectinib Adipate Consumption (2021-2032)
2.9 India Taletrectinib Adipate Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Taletrectinib Adipate Production Value by Manufacturer (2021-2026)
3.2 World Taletrectinib Adipate Production by Manufacturer (2021-2026)
3.3 World Taletrectinib Adipate Average Price by Manufacturer (2021-2026)
3.4 Taletrectinib Adipate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Taletrectinib Adipate Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Taletrectinib Adipate in 2025
3.5.3 Global Concentration Ratios (CR8) for Taletrectinib Adipate in 2025
3.6 Taletrectinib Adipate Market: Overall Company Footprint Analysis
3.6.1 Taletrectinib Adipate Market: Region Footprint
3.6.2 Taletrectinib Adipate Market: Company Product Type Footprint
3.6.3 Taletrectinib Adipate Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Taletrectinib Adipate Production Value Comparison
4.1.1 United States VS China: Taletrectinib Adipate Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Taletrectinib Adipate Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Taletrectinib Adipate Production Comparison
4.2.1 United States VS China: Taletrectinib Adipate Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Taletrectinib Adipate Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Taletrectinib Adipate Consumption Comparison
4.3.1 United States VS China: Taletrectinib Adipate Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Taletrectinib Adipate Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Taletrectinib Adipate Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Taletrectinib Adipate Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Taletrectinib Adipate Production Value (2021-2026)
4.4.3 United States Based Manufacturers Taletrectinib Adipate Production (2021-2026)
4.5 China Based Taletrectinib Adipate Manufacturers and Market Share
4.5.1 China Based Taletrectinib Adipate Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Taletrectinib Adipate Production Value (2021-2026)
4.5.3 China Based Manufacturers Taletrectinib Adipate Production (2021-2026)
4.6 Rest of World Based Taletrectinib Adipate Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Taletrectinib Adipate Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Taletrectinib Adipate Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Taletrectinib Adipate Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Taletrectinib Adipate Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 33 capsules / bottle
5.2.2 30 capsules / bottle
5.3 Market Segment by Type
5.3.1 World Taletrectinib Adipate Production by Type (2021-2032)
5.3.2 World Taletrectinib Adipate Production Value by Type (2021-2032)
5.3.3 World Taletrectinib Adipate Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY INDICATED POPULATION
6.1 World Taletrectinib Adipate Market Size Overview by Indicated Population: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Indicated Population
6.2.1 ROS1 Fusion Gene-Positive Adult Patients with Advanced or Metastatic Non-Small Cell Lung Cancer**
6.2.2 NTRK Fusion Gene-Positive Patients with Advanced Solid Tumors**
6.3 Market Segment by Indicated Population
6.3.1 World Taletrectinib Adipate Production by Indicated Population (2021-2032)
6.3.2 World Taletrectinib Adipate Production Value by Indicated Population (2021-2032)
6.3.3 World Taletrectinib Adipate Average Price by Indicated Population (2021-2032)
7 MARKET ANALYSIS BY SALES CHANNELS
7.1 World Taletrectinib Adipate Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sales Channels
7.2.1 Hospitals
7.2.2 Retail
7.2.3 Online
7.3 Market Segment by Sales Channels
7.3.1 World Taletrectinib Adipate Production by Sales Channels (2021-2032)
7.3.2 World Taletrectinib Adipate Production Value by Sales Channels (2021-2032)
7.3.3 World Taletrectinib Adipate Average Price by Sales Channels (2021-2032)
8 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
8.1 World Taletrectinib Adipate Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Production Technology
8.2.1 Original
8.2.2 Generic
8.3 Market Segment by Production Technology
8.3.1 World Taletrectinib Adipate Production by Production Technology (2021-2032)
8.3.2 World Taletrectinib Adipate Production Value by Production Technology (2021-2032)
8.3.3 World Taletrectinib Adipate Average Price by Production Technology (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Taletrectinib Adipate Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Ros1 Fusion-Positive Locally Advanced
9.2.2 Metastatic Non-Small Cell Lung Cancer (NSCLC)
9.2.3 Others
9.3 Market Segment by Application
9.3.1 World Taletrectinib Adipate Production by Application (2021-2032)
9.3.2 World Taletrectinib Adipate Production Value by Application (2021-2032)
9.3.3 World Taletrectinib Adipate Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 AnHeart Therapeutics
10.1.1 AnHeart Therapeutics Details
10.1.2 AnHeart Therapeutics Major Business
10.1.3 AnHeart Therapeutics Taletrectinib Adipate Product and Services
10.1.4 AnHeart Therapeutics Taletrectinib Adipate Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 AnHeart Therapeutics Recent Developments/Updates
10.1.6 AnHeart Therapeutics Competitive Strengths & Weaknesses
10.2 Innovent Biologics
10.2.1 Innovent Biologics Details
10.2.2 Innovent Biologics Major Business
10.2.3 Innovent Biologics Taletrectinib Adipate Product and Services
10.2.4 Innovent Biologics Taletrectinib Adipate Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Innovent Biologics Recent Developments/Updates
10.2.6 Innovent Biologics Competitive Strengths & Weaknesses
10.3 Asymchem Life Sciences Tianjin) C
10.3.1 Asymchem Life Sciences Tianjin) C Details
10.3.2 Asymchem Life Sciences Tianjin) C Major Business
10.3.3 Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Product and Services
10.3.4 Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Asymchem Life Sciences Tianjin) C Recent Developments/Updates
10.3.6 Asymchem Life Sciences Tianjin) C Competitive Strengths & Weaknesses
10.4 Daiichi Sankyo
10.4.1 Daiichi Sankyo Details
10.4.2 Daiichi Sankyo Major Business
10.4.3 Daiichi Sankyo Taletrectinib Adipate Product and Services
10.4.4 Daiichi Sankyo Taletrectinib Adipate Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Daiichi Sankyo Recent Developments/Updates
10.4.6 Daiichi Sankyo Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Taletrectinib Adipate Industry Chain
11.2 Taletrectinib Adipate Upstream Analysis
11.2.1 Taletrectinib Adipate Core Raw Materials
11.2.2 Main Manufacturers of Taletrectinib Adipate Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Taletrectinib Adipate Production Mode
11.6 Taletrectinib Adipate Procurement Model
11.7 Taletrectinib Adipate Industry Sales Model and Sales Channels
11.7.1 Taletrectinib Adipate Sales Model
11.7.2 Taletrectinib Adipate Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Taletrectinib Adipate Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Taletrectinib Adipate Production Value by Region (2021-2026) & (USD Million)
Table 3. World Taletrectinib Adipate Production Value by Region (2027-2032) & (USD Million)
Table 4. World Taletrectinib Adipate Production Value Market Share by Region (2021-2026)
Table 5. World Taletrectinib Adipate Production Value Market Share by Region (2027-2032)
Table 6. World Taletrectinib Adipate Production by Region (2021-2026) & (Units)
Table 7. World Taletrectinib Adipate Production by Region (2027-2032) & (Units)
Table 8. World Taletrectinib Adipate Production Market Share by Region (2021-2026)
Table 9. World Taletrectinib Adipate Production Market Share by Region (2027-2032)
Table 10. World Taletrectinib Adipate Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Taletrectinib Adipate Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Taletrectinib Adipate Major Market Trends
Table 13. World Taletrectinib Adipate Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Taletrectinib Adipate Consumption by Region (2021-2026) & (Units)
Table 15. World Taletrectinib Adipate Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Taletrectinib Adipate Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Taletrectinib Adipate Producers in 2025
Table 18. World Taletrectinib Adipate Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Taletrectinib Adipate Producers in 2025
Table 20. World Taletrectinib Adipate Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Taletrectinib Adipate Company Evaluation Quadrant
Table 22. World Taletrectinib Adipate Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Taletrectinib Adipate Production Site of Key Manufacturer
Table 24. Taletrectinib Adipate Market: Company Product Type Footprint
Table 25. Taletrectinib Adipate Market: Company Product Application Footprint
Table 26. Taletrectinib Adipate Competitive Factors
Table 27. Taletrectinib Adipate New Entrant and Capacity Expansion Plans
Table 28. Taletrectinib Adipate Mergers & Acquisitions Activity
Table 29. United States VS China Taletrectinib Adipate Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Taletrectinib Adipate Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Taletrectinib Adipate Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Taletrectinib Adipate Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Taletrectinib Adipate Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Taletrectinib Adipate Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Taletrectinib Adipate Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Taletrectinib Adipate Production Market Share (2021-2026)
Table 37. China Based Taletrectinib Adipate Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Taletrectinib Adipate Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Taletrectinib Adipate Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Taletrectinib Adipate Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Taletrectinib Adipate Production Market Share (2021-2026)
Table 42. Rest of World Based Taletrectinib Adipate Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Taletrectinib Adipate Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Taletrectinib Adipate Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Taletrectinib Adipate Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Taletrectinib Adipate Production Market Share (2021-2026)
Table 47. World Taletrectinib Adipate Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Taletrectinib Adipate Production by Type (2021-2026) & (Units)
Table 49. World Taletrectinib Adipate Production by Type (2027-2032) & (Units)
Table 50. World Taletrectinib Adipate Production Value by Type (2021-2026) & (USD Million)
Table 51. World Taletrectinib Adipate Production Value by Type (2027-2032) & (USD Million)
Table 52. World Taletrectinib Adipate Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Taletrectinib Adipate Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Taletrectinib Adipate Production Value by Indicated Population, (USD Million), 2021 & 2025 & 2032
Table 55. World Taletrectinib Adipate Production by Indicated Population (2021-2026) & (Units)
Table 56. World Taletrectinib Adipate Production by Indicated Population (2027-2032) & (Units)
Table 57. World Taletrectinib Adipate Production Value by Indicated Population (2021-2026) & (USD Million)
Table 58. World Taletrectinib Adipate Production Value by Indicated Population (2027-2032) & (USD Million)
Table 59. World Taletrectinib Adipate Average Price by Indicated Population (2021-2026) & (US$/Unit)
Table 60. World Taletrectinib Adipate Average Price by Indicated Population (2027-2032) & (US$/Unit)
Table 61. World Taletrectinib Adipate Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Taletrectinib Adipate Production by Sales Channels (2021-2026) & (Units)
Table 63. World Taletrectinib Adipate Production by Sales Channels (2027-2032) & (Units)
Table 64. World Taletrectinib Adipate Production Value by Sales Channels (2021-2026) & (USD Million)
Table 65. World Taletrectinib Adipate Production Value by Sales Channels (2027-2032) & (USD Million)
Table 66. World Taletrectinib Adipate Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 67. World Taletrectinib Adipate Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 68. World Taletrectinib Adipate Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 69. World Taletrectinib Adipate Production by Production Technology (2021-2026) & (Units)
Table 70. World Taletrectinib Adipate Production by Production Technology (2027-2032) & (Units)
Table 71. World Taletrectinib Adipate Production Value by Production Technology (2021-2026) & (USD Million)
Table 72. World Taletrectinib Adipate Production Value by Production Technology (2027-2032) & (USD Million)
Table 73. World Taletrectinib Adipate Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 74. World Taletrectinib Adipate Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 75. World Taletrectinib Adipate Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Taletrectinib Adipate Production by Application (2021-2026) & (Units)
Table 77. World Taletrectinib Adipate Production by Application (2027-2032) & (Units)
Table 78. World Taletrectinib Adipate Production Value by Application (2021-2026) & (USD Million)
Table 79. World Taletrectinib Adipate Production Value by Application (2027-2032) & (USD Million)
Table 80. World Taletrectinib Adipate Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Taletrectinib Adipate Average Price by Application (2027-2032) & (US$/Unit)
Table 82. AnHeart Therapeutics Basic Information, Manufacturing Base and Competitors
Table 83. AnHeart Therapeutics Major Business
Table 84. AnHeart Therapeutics Taletrectinib Adipate Product and Services
Table 85. AnHeart Therapeutics Taletrectinib Adipate Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. AnHeart Therapeutics Recent Developments/Updates
Table 87. AnHeart Therapeutics Competitive Strengths & Weaknesses
Table 88. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 89. Innovent Biologics Major Business
Table 90. Innovent Biologics Taletrectinib Adipate Product and Services
Table 91. Innovent Biologics Taletrectinib Adipate Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Innovent Biologics Recent Developments/Updates
Table 93. Innovent Biologics Competitive Strengths & Weaknesses
Table 94. Asymchem Life Sciences Tianjin) C Basic Information, Manufacturing Base and Competitors
Table 95. Asymchem Life Sciences Tianjin) C Major Business
Table 96. Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Product and Services
Table 97. Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Asymchem Life Sciences Tianjin) C Recent Developments/Updates
Table 99. Asymchem Life Sciences Tianjin) C Competitive Strengths & Weaknesses
Table 100. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 101. Daiichi Sankyo Major Business
Table 102. Daiichi Sankyo Taletrectinib Adipate Product and Services
Table 103. Daiichi Sankyo Taletrectinib Adipate Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Daiichi Sankyo Recent Developments/Updates
Table 105. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 106. Global Key Players of Taletrectinib Adipate Upstream (Raw Materials)
Table 107. Global Taletrectinib Adipate Typical Customers
Table 108. Taletrectinib Adipate Typical Distributors
Table 1. World Taletrectinib Adipate Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Taletrectinib Adipate Production Value by Region (2021-2026) & (USD Million)
Table 3. World Taletrectinib Adipate Production Value by Region (2027-2032) & (USD Million)
Table 4. World Taletrectinib Adipate Production Value Market Share by Region (2021-2026)
Table 5. World Taletrectinib Adipate Production Value Market Share by Region (2027-2032)
Table 6. World Taletrectinib Adipate Production by Region (2021-2026) & (Units)
Table 7. World Taletrectinib Adipate Production by Region (2027-2032) & (Units)
Table 8. World Taletrectinib Adipate Production Market Share by Region (2021-2026)
Table 9. World Taletrectinib Adipate Production Market Share by Region (2027-2032)
Table 10. World Taletrectinib Adipate Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Taletrectinib Adipate Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Taletrectinib Adipate Major Market Trends
Table 13. World Taletrectinib Adipate Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Taletrectinib Adipate Consumption by Region (2021-2026) & (Units)
Table 15. World Taletrectinib Adipate Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Taletrectinib Adipate Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Taletrectinib Adipate Producers in 2025
Table 18. World Taletrectinib Adipate Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Taletrectinib Adipate Producers in 2025
Table 20. World Taletrectinib Adipate Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Taletrectinib Adipate Company Evaluation Quadrant
Table 22. World Taletrectinib Adipate Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Taletrectinib Adipate Production Site of Key Manufacturer
Table 24. Taletrectinib Adipate Market: Company Product Type Footprint
Table 25. Taletrectinib Adipate Market: Company Product Application Footprint
Table 26. Taletrectinib Adipate Competitive Factors
Table 27. Taletrectinib Adipate New Entrant and Capacity Expansion Plans
Table 28. Taletrectinib Adipate Mergers & Acquisitions Activity
Table 29. United States VS China Taletrectinib Adipate Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Taletrectinib Adipate Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Taletrectinib Adipate Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Taletrectinib Adipate Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Taletrectinib Adipate Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Taletrectinib Adipate Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Taletrectinib Adipate Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Taletrectinib Adipate Production Market Share (2021-2026)
Table 37. China Based Taletrectinib Adipate Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Taletrectinib Adipate Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Taletrectinib Adipate Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Taletrectinib Adipate Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Taletrectinib Adipate Production Market Share (2021-2026)
Table 42. Rest of World Based Taletrectinib Adipate Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Taletrectinib Adipate Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Taletrectinib Adipate Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Taletrectinib Adipate Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Taletrectinib Adipate Production Market Share (2021-2026)
Table 47. World Taletrectinib Adipate Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Taletrectinib Adipate Production by Type (2021-2026) & (Units)
Table 49. World Taletrectinib Adipate Production by Type (2027-2032) & (Units)
Table 50. World Taletrectinib Adipate Production Value by Type (2021-2026) & (USD Million)
Table 51. World Taletrectinib Adipate Production Value by Type (2027-2032) & (USD Million)
Table 52. World Taletrectinib Adipate Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Taletrectinib Adipate Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Taletrectinib Adipate Production Value by Indicated Population, (USD Million), 2021 & 2025 & 2032
Table 55. World Taletrectinib Adipate Production by Indicated Population (2021-2026) & (Units)
Table 56. World Taletrectinib Adipate Production by Indicated Population (2027-2032) & (Units)
Table 57. World Taletrectinib Adipate Production Value by Indicated Population (2021-2026) & (USD Million)
Table 58. World Taletrectinib Adipate Production Value by Indicated Population (2027-2032) & (USD Million)
Table 59. World Taletrectinib Adipate Average Price by Indicated Population (2021-2026) & (US$/Unit)
Table 60. World Taletrectinib Adipate Average Price by Indicated Population (2027-2032) & (US$/Unit)
Table 61. World Taletrectinib Adipate Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Taletrectinib Adipate Production by Sales Channels (2021-2026) & (Units)
Table 63. World Taletrectinib Adipate Production by Sales Channels (2027-2032) & (Units)
Table 64. World Taletrectinib Adipate Production Value by Sales Channels (2021-2026) & (USD Million)
Table 65. World Taletrectinib Adipate Production Value by Sales Channels (2027-2032) & (USD Million)
Table 66. World Taletrectinib Adipate Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 67. World Taletrectinib Adipate Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 68. World Taletrectinib Adipate Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 69. World Taletrectinib Adipate Production by Production Technology (2021-2026) & (Units)
Table 70. World Taletrectinib Adipate Production by Production Technology (2027-2032) & (Units)
Table 71. World Taletrectinib Adipate Production Value by Production Technology (2021-2026) & (USD Million)
Table 72. World Taletrectinib Adipate Production Value by Production Technology (2027-2032) & (USD Million)
Table 73. World Taletrectinib Adipate Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 74. World Taletrectinib Adipate Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 75. World Taletrectinib Adipate Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Taletrectinib Adipate Production by Application (2021-2026) & (Units)
Table 77. World Taletrectinib Adipate Production by Application (2027-2032) & (Units)
Table 78. World Taletrectinib Adipate Production Value by Application (2021-2026) & (USD Million)
Table 79. World Taletrectinib Adipate Production Value by Application (2027-2032) & (USD Million)
Table 80. World Taletrectinib Adipate Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Taletrectinib Adipate Average Price by Application (2027-2032) & (US$/Unit)
Table 82. AnHeart Therapeutics Basic Information, Manufacturing Base and Competitors
Table 83. AnHeart Therapeutics Major Business
Table 84. AnHeart Therapeutics Taletrectinib Adipate Product and Services
Table 85. AnHeart Therapeutics Taletrectinib Adipate Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. AnHeart Therapeutics Recent Developments/Updates
Table 87. AnHeart Therapeutics Competitive Strengths & Weaknesses
Table 88. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 89. Innovent Biologics Major Business
Table 90. Innovent Biologics Taletrectinib Adipate Product and Services
Table 91. Innovent Biologics Taletrectinib Adipate Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Innovent Biologics Recent Developments/Updates
Table 93. Innovent Biologics Competitive Strengths & Weaknesses
Table 94. Asymchem Life Sciences Tianjin) C Basic Information, Manufacturing Base and Competitors
Table 95. Asymchem Life Sciences Tianjin) C Major Business
Table 96. Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Product and Services
Table 97. Asymchem Life Sciences Tianjin) C Taletrectinib Adipate Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Asymchem Life Sciences Tianjin) C Recent Developments/Updates
Table 99. Asymchem Life Sciences Tianjin) C Competitive Strengths & Weaknesses
Table 100. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 101. Daiichi Sankyo Major Business
Table 102. Daiichi Sankyo Taletrectinib Adipate Product and Services
Table 103. Daiichi Sankyo Taletrectinib Adipate Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Daiichi Sankyo Recent Developments/Updates
Table 105. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 106. Global Key Players of Taletrectinib Adipate Upstream (Raw Materials)
Table 107. Global Taletrectinib Adipate Typical Customers
Table 108. Taletrectinib Adipate Typical Distributors
LIST OF FIGURES
Figure 1. Taletrectinib Adipate Picture
Figure 2. World Taletrectinib Adipate Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Taletrectinib Adipate Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Taletrectinib Adipate Production (2021-2032) & (Units)
Figure 5. World Taletrectinib Adipate Average Price (2021-2032) & (US$/Unit)
Figure 6. World Taletrectinib Adipate Production Value Market Share by Region (2021-2032)
Figure 7. World Taletrectinib Adipate Production Market Share by Region (2021-2032)
Figure 8. North America Taletrectinib Adipate Production (2021-2032) & (Units)
Figure 9. Europe Taletrectinib Adipate Production (2021-2032) & (Units)
Figure 10. China Taletrectinib Adipate Production (2021-2032) & (Units)
Figure 11. Japan Taletrectinib Adipate Production (2021-2032) & (Units)
Figure 12. India Taletrectinib Adipate Production (2021-2032) & (Units)
Figure 13. Taletrectinib Adipate Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 16. World Taletrectinib Adipate Consumption Market Share by Region (2021-2032)
Figure 17. United States Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 18. China Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 19. Europe Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 20. Japan Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 21. South Korea Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 22. ASEAN Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 23. India Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Taletrectinib Adipate by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Taletrectinib Adipate Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Taletrectinib Adipate Markets in 2025
Figure 27. United States VS China: Taletrectinib Adipate Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Taletrectinib Adipate Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Taletrectinib Adipate Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Taletrectinib Adipate Production Market Share 2025
Figure 31. China Based Manufacturers Taletrectinib Adipate Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Taletrectinib Adipate Production Market Share 2025
Figure 33. World Taletrectinib Adipate Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Taletrectinib Adipate Production Value Market Share by Type in 2025
Figure 35. 33 capsules / bottle
Figure 36. 30 capsules / bottle
Figure 37. World Taletrectinib Adipate Production Market Share by Type (2021-2032)
Figure 38. World Taletrectinib Adipate Production Value Market Share by Type (2021-2032)
Figure 39. World Taletrectinib Adipate Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Taletrectinib Adipate Production Value by Indicated Population, (USD Million), 2021 & 2025 & 2032
Figure 41. World Taletrectinib Adipate Production Value Market Share by Indicated Population in 2025
Figure 42. ROS1 Fusion Gene-Positive Adult Patients with Advanced or Metastatic Non-Small Cell Lung Cancer**
Figure 43. NTRK Fusion Gene-Positive Patients with Advanced Solid Tumors**
Figure 44. World Taletrectinib Adipate Production Market Share by Indicated Population (2021-2032)
Figure 45. World Taletrectinib Adipate Production Value Market Share by Indicated Population (2021-2032)
Figure 46. World Taletrectinib Adipate Average Price by Indicated Population (2021-2032) & (US$/Unit)
Figure 47. World Taletrectinib Adipate Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 48. World Taletrectinib Adipate Production Value Market Share by Sales Channels in 2025
Figure 49. Hospitals
Figure 50. Retail
Figure 51. Online
Figure 52. World Taletrectinib Adipate Production Market Share by Sales Channels (2021-2032)
Figure 53. World Taletrectinib Adipate Production Value Market Share by Sales Channels (2021-2032)
Figure 54. World Taletrectinib Adipate Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 55. World Taletrectinib Adipate Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 56. World Taletrectinib Adipate Production Value Market Share by Production Technology in 2025
Figure 57. Original
Figure 58. Generic
Figure 59. World Taletrectinib Adipate Production Market Share by Production Technology (2021-2032)
Figure 60. World Taletrectinib Adipate Production Value Market Share by Production Technology (2021-2032)
Figure 61. World Taletrectinib Adipate Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 62. World Taletrectinib Adipate Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World Taletrectinib Adipate Production Value Market Share by Application in 2025
Figure 64. Ros1 Fusion-Positive Locally Advanced
Figure 65. Metastatic Non-Small Cell Lung Cancer (NSCLC)
Figure 66. Others
Figure 67. World Taletrectinib Adipate Production Market Share by Application (2021-2032)
Figure 68. World Taletrectinib Adipate Production Value Market Share by Application (2021-2032)
Figure 69. World Taletrectinib Adipate Average Price by Application (2021-2032) & (US$/Unit)
Figure 70. Taletrectinib Adipate Industry Chain
Figure 71. Taletrectinib Adipate Procurement Model
Figure 72. Taletrectinib Adipate Sales Model
Figure 73. Taletrectinib Adipate Sales Channels, Direct Sales, and Distribution
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Taletrectinib Adipate Picture
Figure 2. World Taletrectinib Adipate Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Taletrectinib Adipate Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Taletrectinib Adipate Production (2021-2032) & (Units)
Figure 5. World Taletrectinib Adipate Average Price (2021-2032) & (US$/Unit)
Figure 6. World Taletrectinib Adipate Production Value Market Share by Region (2021-2032)
Figure 7. World Taletrectinib Adipate Production Market Share by Region (2021-2032)
Figure 8. North America Taletrectinib Adipate Production (2021-2032) & (Units)
Figure 9. Europe Taletrectinib Adipate Production (2021-2032) & (Units)
Figure 10. China Taletrectinib Adipate Production (2021-2032) & (Units)
Figure 11. Japan Taletrectinib Adipate Production (2021-2032) & (Units)
Figure 12. India Taletrectinib Adipate Production (2021-2032) & (Units)
Figure 13. Taletrectinib Adipate Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 16. World Taletrectinib Adipate Consumption Market Share by Region (2021-2032)
Figure 17. United States Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 18. China Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 19. Europe Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 20. Japan Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 21. South Korea Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 22. ASEAN Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 23. India Taletrectinib Adipate Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Taletrectinib Adipate by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Taletrectinib Adipate Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Taletrectinib Adipate Markets in 2025
Figure 27. United States VS China: Taletrectinib Adipate Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Taletrectinib Adipate Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Taletrectinib Adipate Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Taletrectinib Adipate Production Market Share 2025
Figure 31. China Based Manufacturers Taletrectinib Adipate Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Taletrectinib Adipate Production Market Share 2025
Figure 33. World Taletrectinib Adipate Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Taletrectinib Adipate Production Value Market Share by Type in 2025
Figure 35. 33 capsules / bottle
Figure 36. 30 capsules / bottle
Figure 37. World Taletrectinib Adipate Production Market Share by Type (2021-2032)
Figure 38. World Taletrectinib Adipate Production Value Market Share by Type (2021-2032)
Figure 39. World Taletrectinib Adipate Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Taletrectinib Adipate Production Value by Indicated Population, (USD Million), 2021 & 2025 & 2032
Figure 41. World Taletrectinib Adipate Production Value Market Share by Indicated Population in 2025
Figure 42. ROS1 Fusion Gene-Positive Adult Patients with Advanced or Metastatic Non-Small Cell Lung Cancer**
Figure 43. NTRK Fusion Gene-Positive Patients with Advanced Solid Tumors**
Figure 44. World Taletrectinib Adipate Production Market Share by Indicated Population (2021-2032)
Figure 45. World Taletrectinib Adipate Production Value Market Share by Indicated Population (2021-2032)
Figure 46. World Taletrectinib Adipate Average Price by Indicated Population (2021-2032) & (US$/Unit)
Figure 47. World Taletrectinib Adipate Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 48. World Taletrectinib Adipate Production Value Market Share by Sales Channels in 2025
Figure 49. Hospitals
Figure 50. Retail
Figure 51. Online
Figure 52. World Taletrectinib Adipate Production Market Share by Sales Channels (2021-2032)
Figure 53. World Taletrectinib Adipate Production Value Market Share by Sales Channels (2021-2032)
Figure 54. World Taletrectinib Adipate Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 55. World Taletrectinib Adipate Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 56. World Taletrectinib Adipate Production Value Market Share by Production Technology in 2025
Figure 57. Original
Figure 58. Generic
Figure 59. World Taletrectinib Adipate Production Market Share by Production Technology (2021-2032)
Figure 60. World Taletrectinib Adipate Production Value Market Share by Production Technology (2021-2032)
Figure 61. World Taletrectinib Adipate Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 62. World Taletrectinib Adipate Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World Taletrectinib Adipate Production Value Market Share by Application in 2025
Figure 64. Ros1 Fusion-Positive Locally Advanced
Figure 65. Metastatic Non-Small Cell Lung Cancer (NSCLC)
Figure 66. Others
Figure 67. World Taletrectinib Adipate Production Market Share by Application (2021-2032)
Figure 68. World Taletrectinib Adipate Production Value Market Share by Application (2021-2032)
Figure 69. World Taletrectinib Adipate Average Price by Application (2021-2032) & (US$/Unit)
Figure 70. Taletrectinib Adipate Industry Chain
Figure 71. Taletrectinib Adipate Procurement Model
Figure 72. Taletrectinib Adipate Sales Model
Figure 73. Taletrectinib Adipate Sales Channels, Direct Sales, and Distribution
Figure 74. Methodology
Figure 75. Research Process and Data Source
